A Polymer-based, Paclitaxel-eluting Stent In Patients With Coronary Artery Disease
Gregg W Stone, Stephen G Ellis, David A. Cox
Published 2004 · Medicine
Download PDFAnalyze on Scholarcy
This paper is referenced by
Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
Michael S Lee (2008)
Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.
Gerald S Werner (2004)
Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
Pasi P Karjalainen (2007)
Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients
Pak-hei Chan (2013)
A cath lab hero is something to be? Comments on left main stem percutaneous coronary intervention for ST-elevation myocardial infarction
Lars Grip (2005)
Drug‐eluting versus third‐generation bare metal stents: The US strategy
Daniel W Isenbarger (2005)
Safety of drug-coated stents
Giuseppe Biondi-Zoccai (2008)
Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: A cross-sectional study
Mohammad Alidoosti (2007)
Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up.
Xavier Freixa (2012)
Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?
S. K. Silber (2004)
Die Stentthrombose im Fokus von Drug-eluting Stents
Jochen Woehrle (2007)
Herz Drug-Eluting Stents for In-Stent Restenosis and Acute Myocardial Infarction Present Data from Nonrandomized Studies
Joachim Schofer (2004)
Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography
Dr. med. L. Buellesfeld (2005)
Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies.
Fumei Huang (2015)
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studies
Nobuaki Kobayashi (2014)
CURRENT STATUS AND FUTURE PERSPECTIVES ON DRUG-ELUTING BIORESORBABLE CORONARY SCAFFOLDS: WILL THE PARADIGM OF PCI SHIFT?
Alfonso Ielasi (2014)
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.
Gregg W Stone (2005)
On cellular sources for intimal hyperplasia after vascular interventions
Stefan Mellander (2007)
Coronary plaque characteristics on baseline CT predict the need for late revascularization in symptomatic patients after percutaneous intervention
Mengmeng Yu (2018)
Prevention of restenosis by systemic drug therapy: back to the future?
Albert Schoemig (2005)
Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
Yunjun Xiao (2013)
Pathology of Endovascular Stents.
Kenta Nakamura (2016)
Local Stent-Based Release of Transforming Growth Factor–β1 Limits Arterial In-Stent Restenosis
David S. Wang (2016)
Systematic Review of Therapies for Stable Coronary Artery Disease in Diabetic Patients.
Suvitesh Luthra (2015)
Patrick W. Serruys (2006)
Optimal Stenting in Saphenous Vein Graft Intervention.
Gabriel Maluenda (2013)
Coronary stents: historical development, current status and future directions.
Javaid Iqbal (2013)
PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
Erik Walter Holy (2014)
Restenosis and drug-eluting stents.
Robert Winslow (2005)
Techniques for the diagnosis of vertebral artery origin stenosis and considerations for determining treatment and timing
Edgar A Samaniego (2012)
Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice
Keith D. Dawkins (2005)
Contemporary Patterns of Discharge Aspirin Dosing After Acute Myocardial Infarction in the United States: Results From the National Cardiovascular Data Registry (NCDR)
Hurst M. Hall (2014)See more